基本信息
浏览量:1
职业迁徙
个人简介
My research focuses on immunotherapy in cancer with a special focus on skin cancers such as melanoma. I have designed and conducted numerous Phase I and II clinical trials. A collaboration with Dr Richard Heller has resulted in intratumoral IL12 as a treatment for melanoma. At UCSF, I co-direct the melanoma program and am the PI of several early phase and melanoma specific clinical trials as well as collaborating with my colleagues Michael Rosenblum, Max Krummel, Matt Spitzer and Jeff Bluestone at UCSF as well as other national experts in melanoma patients progressing on immunotherapy. One of the areas I am interested in is immunotherapy with PD-1 antibodies and in understanding resistance to PD-1 especially site specific immunity.
研究兴趣
论文共 89 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Alexandra M Haugh, Robert C Osorio, Rony A Francois, Michael E Tawil,Katy K Tsai,Michael Tetzlaff,Adil Daud,Harish N Vasudevan
MOLECULAR CANCERno. 1 (2024)
Alexandra M Haugh,Adil I Daud
Cancer journal (Sudbury, Mass.)no. 2 (2024): 108-112
Alexandra Haugh,Adil I. Daud
American Journal of Clinical Dermatologypp.1-13, (2024)
crossref(2023)
IMMUNITYno. 9 (2022): 1749-1749
Springer eBookspp.709-718, (2022)
Immunityno. 9 (2022): 1749-1749
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn